WAI CHUN BIOTEC (00660) Issues Positive Profit Alert, Expects Annual Results to Turn Around Year-on-Year to Not Less Than HK$30 Million
WAI CHUN BIOTEC (00660) announced that the Group expects to record a profit of not less than HK$30 million for the year ended June 30, 2026, compared with a net loss of approximately HK$10.7 million in the same period of 2025. The expected turnaround from loss to profit for the year is mainly attributable to a one-off reversal of impairment loss on property, plant and equipment of approximately HK$52.1 million, resulting from significant improvement in the actual operating performance and prospects of the cash-generating unit for the production and sale of modified starch, which amount was partly offset by a reversal of deferred tax assets of approximately HK$15 million.
WAI CHUN BIOTEC (00660) announced that the group expects to record a profit of not less than HK$30 million for the year ended June 30, 2026, compared with a net loss of approximately HK$10.7 million in the same period of 2025. The expected turnaround from loss to profit for the year is mainly attributable to a significant improvement in the actual operating performance and prospects of the modified starch production and sales cash-generating unit, resulting in a one-off reversal of impairment losses on property, plant and equipment of approximately HK$52.1 million, which was partly offset by a reversal of deferred tax assets of approximately HK$15 million.
Related Articles

BEKE-W (02423) repurchased approximately 248,600 shares for about US$1.5 million on November 10.

CALC (01848) issues 7.8723 million shares under scrip dividend scheme

TEXWINCA HOLD (00321) announces interim results: profit attributable to ordinary equity holders approximately HK$54 million, down 51.8% year-on-year.
BEKE-W (02423) repurchased approximately 248,600 shares for about US$1.5 million on November 10.

CALC (01848) issues 7.8723 million shares under scrip dividend scheme

TEXWINCA HOLD (00321) announces interim results: profit attributable to ordinary equity holders approximately HK$54 million, down 51.8% year-on-year.






